May 04 to 05 2015, Santa Clara, USA.

Speakers

Speaker "Kameshwar Eranki" Details

Name :
kameshwar eranki
Company :
Title :
CEO
Topic :

Building Drug Safety & Risk Monitoring Systems leveraging Big data and analytics

Abstract :

Pharmaceutical and biotech companies are involved in producing human drugs to provide better cures for various health issues. Often, end-to-end drug life cycle management is complex and long drawn process spanning multi-year timelines and involves several key phases starting from R&D Bench to patent protection to drug product, regulatory compliance to post market drug safety through adverse event intelligence and patient drug consumption & outcomes. The combining of heterogeneous and non-standard data sets from multiple data points poses immense data merging challenges on one hand, and provides unprecedented opportunity to leverage big data and analytics in delivering actionable intelligence to make right decisions at right time and improve drug safety, product quality and creating new products & improving patient outcomes and saving valuable human lives.

Profile :

Kameshwar Eranki is Founder, CEO of VajraSoft Inc., a Intellectual Property Software development company based in Silicon Valley, helping customers manage innovations and monetize of IP's. Kameshwar has delivered several award winning Cloud applications and Big data driven analytics applications, driving growth. He has over 22 years of Software Product Development and Business Development experience and has provided solutions across biotech, pharma, semiconductor, energy, finance and manufacturing verticals. He is recognized leader in big data, Cloud Computing and as global IP expert.

Kameshwar holds Master of Science in E-Business Systems and Technologies from Golden Gate University, San Francisco, USA and Master of Science in Electronic Commerce, Golden Gate University, San Francisco.

x

Get latest updates of Global Data Science Conference
sent to your inbox.

Weekly insight from industry insiders.
Plus exclusive content and offers.